Victor Sung, M.D., director of the Division of Movement Disorders in the University of Alabama at Birmingham Department of ...

“Beyond UniQure, the pipeline includes highly promising approaches that will ideally move the goal from merely managing ...

As well as slowing disease progression by 75 percent at 36 months, the scientists found that neurofilament light protein (NfL ...

Huntington’s disease is a hereditary brain disorder that impacts movement, mood, and cognitive abilities. It gets worse over ...

The neurodegenerative disease damages patients' motor, cognitive and behavioral controls, which sometimes manifest as ...

After years of heartbreak, researchers have found an experimental treatment that can slow the progression of Huntington’s ...

For decades, so many families have watched loved ones suffer from Huntington's disease, a neurodegenerative condition that progressively worsens over time. But now, there is finally a light at the end ...

TAMPA, Fla. (WFLA) — For the first time, scientists have successfully treated someone suffering from Huntington’s disease, a fatal genetic illness with no cure. The Mayo Clinic reports that the ...

Gene therapy is becoming a powerful way to treat challenging diseases that don’t respond to traditional treatments, and researchers now report the first success in modifying genes to slow Huntington’s ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented new data from the open-label KINECT®-HD2 study demonstrating an established long-term safety profile, tolerability and sustained ...